BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17099780)

  • 21. Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration.
    De Wever W; Stroobants S; Coolen J; Verschakelen JA
    Eur Respir J; 2009 Jan; 33(1):201-12. PubMed ID: 19118231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lung Cancer Assessment Using MR Imaging: An Update.
    Ohno Y; Koyama H; Yoshikawa T; Matsumoto S; Sugimura K
    Magn Reson Imaging Clin N Am; 2015 May; 23(2):231-44. PubMed ID: 25952517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging lung cancer.
    Patz EF
    Semin Oncol; 1999 Oct; 26(5 Suppl 15):21-6. PubMed ID: 10566607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis and management of pancreatic cancer; comparison with multidetector row computed tomography, magnetic resonance imaging and endoscopic ultrasonography.
    Ergul N; Gundogan C; Tozlu M; Toprak H; Kadıoglu H; Aydin M; Cermik TF
    Rev Esp Med Nucl Imagen Mol; 2014; 33(3):159-64. PubMed ID: 24140024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of advantages of positron emission tomography over computed tomography for N-staging in lung cancer patients.
    Ebihara A; Nomori H; Watanabe K; Ohtsuka T; Naruke T; Uno K; Kuwahira I; Eguchi K
    Jpn J Clin Oncol; 2006 Nov; 36(11):694-8. PubMed ID: 17068084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CT and PET imaging in non-small cell lung cancer.
    Knoepp UW; Ravenel JG
    Crit Rev Oncol Hematol; 2006 Apr; 58(1):15-30. PubMed ID: 16386435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The usefulness of PET/CT in lung cancer].
    Pinilla I; Gómez León N
    Radiologia; 2009; 51(3):248-60. PubMed ID: 19406442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lung neoplasms--CT screening for better early identification].
    Pneumologie; 2008 Apr; 62(4):185. PubMed ID: 18393175
    [No Abstract]   [Full Text] [Related]  

  • 30. Positron emission tomography/magnetic resonance imaging evaluation of lung cancer: current status and future prospects.
    Yoon SH; Goo JM; Lee SM; Park CM; Seo HJ; Cheon GJ
    J Thorac Imaging; 2014 Jan; 29(1):4-16. PubMed ID: 24296699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging techniques for diagnosis and staging of lung cancer.
    McLoud TC
    Clin Chest Med; 2002 Mar; 23(1):123-36. PubMed ID: 11901907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging of tumor viability in lung cancer: initial results using 23Na-MRI.
    Henzler T; Konstandin S; Schmid-Bindert G; Apfaltrer P; Haneder S; Wenz F; Schad L; Manegold C; Schoenberg SO; Fink C
    Rofo; 2012 Apr; 184(4):340-4. PubMed ID: 22351502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pediatric bone sarcoma: diagnostic performance of ¹⁸F-FDG PET/CT versus conventional imaging for initial staging and follow-up.
    Quartuccio N; Fox J; Kuk D; Wexler LH; Baldari S; Cistaro A; Schöder H
    AJR Am J Roentgenol; 2015 Jan; 204(1):153-60. PubMed ID: 25539251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiologic diagnosis of extrathoracic metastases to the lung.
    Woodard PK; Dehdashti F; Putman CE
    Oncology (Williston Park); 1998 Mar; 12(3):431-8; discussion 441-2, 444. PubMed ID: 9534193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain metastasis in lung cancer. Comparison of cerebral MRI and 18F-FDG-PET/CT for diagnosis in the initial staging.
    Krüger S; Mottaghy FM; Buck AK; Maschke S; Kley H; Frechen D; Wibmer T; Reske SN; Pauls S
    Nuklearmedizin; 2011; 50(3):101-6. PubMed ID: 21165538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computed tomography, positron emission tomography, positron emission tomography/computed tomography, and magnetic resonance imaging for staging of limited pleural mesothelioma: initial results.
    Plathow C; Staab A; Schmaehl A; Aschoff P; Zuna I; Pfannenberg C; Peter SH; Eschmann S; Klopp M
    Invest Radiol; 2008 Oct; 43(10):737-44. PubMed ID: 18791416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CT Screening for lung cancer: diagnoses resulting from the New York Early Lung Cancer Action Project.
    New York Early Lung Cancer Action Project Investigators
    Radiology; 2007 Apr; 243(1):239-49. PubMed ID: 17392256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CT and MRI of Lung Cancer.
    Laurent F; Montaudon M; Corneloup O
    Respiration; 2006; 73(2):133-42. PubMed ID: 16549940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of whole-body MRI to detect the recurrence of lung cancer.
    Lee MH; Kim SR; Park SY; Park SJ; Lee EJ; Jin GY; Lee YC
    Magn Reson Imaging; 2012 Dec; 30(10):1439-45. PubMed ID: 22817957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging.
    Yi CA; Shin KM; Lee KS; Kim BT; Kim H; Kwon OJ; Choi JY; Chung MJ
    Radiology; 2008 Aug; 248(2):632-42. PubMed ID: 18552311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.